Gene expression within the apicoplast, an organelle in the malaria parasite Plasmodium falciparum, is regulated by melatonin (the circadian signaling hormone) in host blood and intrinsic parasite cues, via a factor called ApSigma, as identified by a recent study aided by Tokyo Tech’s World Research Hub Initiative. The regulatory system highlighted in this study might be a future target for malaria treatment. Read More